Company Filing History:
Years Active: 2016-2022
Title: Laetitia Martin: Innovator in Pharmaceutical Compounds
Introduction
Laetitia Martin is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases characterized by excessive or abnormal cell proliferation, such as cancer. With a total of 2 patents to her name, her work is paving the way for innovative treatments.
Latest Patents
Laetitia's latest patents include groundbreaking inventions related to pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9. The first patent encompasses compounds of general formula (I), wherein the groups R to R, X, and X have specific meanings as defined in the claims and specification. These compounds are designed for the treatment of diseases characterized by excessive or abnormal cell proliferation. The second patent also focuses on pyridinones, with similar applications in treating such diseases and includes pharmaceutical preparations containing these compounds.
Career Highlights
Laetitia Martin is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her work at the company emphasizes her commitment to advancing medical science and improving patient outcomes through innovative drug development.
Collaborations
Laetitia collaborates with esteemed colleagues, including Steffen Steurer and Xiao-Ling Cockcroft. These partnerships enhance her research and contribute to the success of her innovative projects.
Conclusion
Laetitia Martin's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a key innovator in the industry. Her work continues to inspire advancements in the treatment of serious diseases.